Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients
A Non-randomized, Open-label, Multi-center, Phase I/II Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Copanlisib in Pediatric Patients With Relapsed/Refractory Solid Tumors or Lymphoma
Sponsor: Bayer
Terminated
no anticipated benefit over available standard therapies
Other terminated trials from Bayer
Other Ewing Sarcoma trials with similar outcome
A PHASE1/PHASE2 clinical study on Ewing Sarcoma and Neuroblastoma, this trial is terminated or withdrawn. The trial is conducted by Bayer and has accumulated 59 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
59 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE1/PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2024 — Jul 2024 [monthly]
Terminated PHASE1_PHASE2
-
Apr 2023 — Jan 2024 [monthly]
Terminated PHASE1_PHASE2
Status: Recruiting → Terminated
▶ Show 54 earlier versions
-
Feb 2023 — Apr 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2023 — Feb 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Nov 2022 — Dec 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Sep 2022 — Nov 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Jul 2022 — Sep 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2022 — Jul 2022 [monthly]
Recruiting PHASE1_PHASE2
-
May 2022 — Jun 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Apr 2022 — May 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2022 — Apr 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2022 — Feb 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Dec 2021 — Jan 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Nov 2021 — Dec 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Oct 2021 — Nov 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Sep 2021 — Oct 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2021 — Sep 2021 [monthly]
Recruiting PHASE1_PHASE2
-
May 2021 — Jun 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Apr 2021 — May 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2021 — Apr 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2021 — Mar 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Nov 2020 — Dec 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Oct 2020 — Nov 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Sep 2020 — Oct 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Aug 2020 — Sep 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Jul 2020 — Aug 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2020 — Jul 2020 [monthly]
Recruiting PHASE1_PHASE2
-
May 2020 — Jun 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Apr 2020 — May 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2020 — Apr 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2020 — Mar 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2020 — Feb 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Dec 2019 — Jan 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Nov 2019 — Dec 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Oct 2019 — Nov 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Sep 2019 — Oct 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Aug 2019 — Sep 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Jul 2019 — Aug 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2019 — Jul 2019 [monthly]
Recruiting PHASE1_PHASE2
-
May 2019 — Jun 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Apr 2019 — May 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2019 — Apr 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2019 — Mar 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2019 — Feb 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Dec 2018 — Jan 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Nov 2018 — Dec 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Oct 2018 — Nov 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Sep 2018 — Oct 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Aug 2018 — Sep 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Jul 2018 — Aug 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE1_PHASE2
Status: Not Yet Recruiting → Recruiting
-
May 2018 — Jun 2018 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Mar 2018 — May 2018 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Bayer
For direct contact, visit the study record on ClinicalTrials.gov .